Understanding the measurement relationship between EQ-5D-5L, PROMIS-29 and PROPr

被引:3
作者
Mulhern, Brendan J. [1 ]
Pan, Tianxin [2 ]
Norman, Richard [3 ]
Tran-Duy, An [2 ]
Hanmer, Janel [4 ]
Viney, Rosalie [1 ]
Devlin, Nancy J. [2 ]
机构
[1] Univ Technol Sydney, Ctr Hlth Econ Res & Evaluat, Ultimo, NSW, Australia
[2] Univ Melbourne, Ctr Hlth Policy, Melbourne Sch Populat & Global Hlth, Hlth Econ Unit, Parkville, Vic, Australia
[3] Curtin Univ, Sch Populat Hlth, Perth, WA, Australia
[4] Univ Pittsburgh, Dept Gen Internal Med, Pittsburgh, PA USA
关键词
EQ-5D-5L; PROMIS; Health-related quality of life; Psychometrics; INFORMATION-SYSTEM PROMIS; ITEM BANKS; OUTCOMES; EUROQOL; STATE;
D O I
10.1007/s11136-023-03462-6
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
PurposeMany generic patient-reported instruments are available for the measurement of health outcomes, including EQ-5D-5L, and the Patient-Reported Outcome Measurement Information System (PROMIS). Assessing their measurement characteristics informs users about the consistency between, and limits of, evidence produced. The aim was to assess the measurement relationship between the EQ-5D-5L descriptive system and value sets, the PROMIS-29 and PROPr (PROMIS value set).MethodsData were extracted from a cross-sectional survey administering measures of quality of life online in Australia. Descriptive analysis, agreement and construct validity assessment methods were used to compare instruments at the item, domain and value set level.ResultsIn total, 794 Australians completed the survey. Convergent validity analysis found that similar dimensions across instruments were highly correlated (> 0.50), but the PROMIS-29 assesses additional health concepts not explicitly covered by EQ-5D (sleep and fatigue). Known-group assessment found that EQ-5D-5L and PROPr were able to detect those with and without a condition (ES range 0.78-0.83) but PROPr could more precisely detect differing levels of self-reported health. Both instruments were sensitive to differences in levels of pain.DiscussionThere is some consistency in what the EQ-5D-5L, PROMIS-29 and PROPr measure. Differences between value set characteristics can be linked to differences what is measured and the valuation approaches used. This has implications for the use of each in assessing health outcomes, and the results can inform decisions about which instrument should be used in which context.
引用
收藏
页码:3147 / 3160
页数:14
相关论文
共 50 条
  • [41] Comparing the measurement properties of the EQ-5D-5L and the EQ-5D-3L in hypertensive patients living in rural China
    Jiang, Jie
    Hong, Yanming
    Zhang, Tiantian
    Yang, Zhihao
    Lin, Tengfei
    Liang, Zhuoru
    Lu, Peiyao
    Liu, Lishun
    Wang, Binyan
    Xu, Yongmei
    Luo, Nan
    QUALITY OF LIFE RESEARCH, 2021, 30 (07) : 2045 - 2060
  • [42] EQ-5D-5L Portuguese population norms
    Ferreira, Pedro L.
    Pereira, Luis N.
    Antunes, Patricia
    Ferreira, Lara N. N.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2023, 24 (09) : 1411 - 1420
  • [43] Comparing the measurement properties of the EQ-5D-5L and the EQ-5D-3L in hypertensive patients living in rural China
    Jie Jiang
    Yanming Hong
    Tiantian Zhang
    Zhihao Yang
    Tengfei Lin
    Zhuoru Liang
    Peiyao Lu
    Lishun Liu
    Binyan Wang
    Yongmei Xu
    Nan Luo
    Quality of Life Research, 2021, 30 : 2045 - 2060
  • [44] The EQ-5D-5L Valuation study in Thailand
    Pattanaphesaj, Juntana
    Thavorncharoensap, Montarat
    Ramos-Goni, Juan Manuel
    Tongsiri, Sirinart
    Ingsrisawang, Lily
    Teerawattananon, Yot
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2018, 18 (05) : 551 - 558
  • [45] EQ-5D-5L: a value set for Romania
    Olariu, Elena
    Mohammed, Wael
    Oluboyede, Yemi
    Caplescu, Raluca
    Niculescu-Aron, Ileana Gabriela
    Paveliu, Marian Sorin
    Vale, Luke
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2023, 24 (03) : 399 - 412
  • [46] The Indonesian EQ-5D-5L Value Set
    Purba, Fredrick Dermawan
    Hunfeld, Joke A. M.
    Iskandarsyah, Aulia
    Fitriana, Titi Sahidah
    Sadarjoen, Sawitri Supardi
    Ramos-Goni, Juan Manuel
    Passchier, Jan
    Busschbach, Jan J. V.
    PHARMACOECONOMICS, 2017, 35 (11) : 1153 - 1165
  • [47] Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study
    M. F. Janssen
    A. Simon Pickard
    Dominik Golicki
    Claire Gudex
    Maciej Niewada
    Luciana Scalone
    Paul Swinburn
    Jan Busschbach
    Quality of Life Research, 2013, 22 : 1717 - 1727
  • [48] EQ-5D-5L Bulgarian population norms
    Encheva, Marta
    Djambazov, Slaveyko
    Vekov, Toni
    Golicki, Dominik
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2020, 21 (08) : 1169 - 1178
  • [49] EQ-5D-5L Portuguese population norms
    Pedro L. Ferreira
    Luís N. Pereira
    Patrícia Antunes
    Lara N. Ferreira
    The European Journal of Health Economics, 2023, 24 : 1411 - 1420
  • [50] The EQ-5D-5L Valuation Study in Egypt
    Al Shabasy, Sahar A.
    Abbassi, Maggie M.
    Finch, Aureliano Paolo
    Baines, Darrin
    Farid, Samar F.
    PHARMACOECONOMICS, 2022, 40 (04) : 433 - 447